Mia's Feed
Medical News & Research

Reversing Obesity's Impact: How Weight Loss Restores the Inflammatory Function of Fat-Derived Stem Cells Over Time

Reversing Obesity's Impact: How Weight Loss Restores the Inflammatory Function of Fat-Derived Stem Cells Over Time

Share this article

New studies reveal that adipose-derived stem cells retain signs of obesity’s impact long after weight loss, with regenerative functions only gradually recovering over years. Learn how cellular inflammation regulation is affected post-weight reduction.

2 min read

Recent research has provided new insights into how adipose-derived stem cells (ADSCs), originating from fat tissue, respond to obesity and subsequent weight loss. These stem cells play a crucial role in tissue repair, immune regulation, and regenerative therapies. Notably, obesity impairs their anti-inflammatory capabilities, which are essential for combating systemic inflammation. While weight loss through bariatric surgery leads to measurable reductions in systemic inflammation, the functional recovery of these stem cells is more complex.

A groundbreaking study conducted by Tampere University examined adipose tissue from the same donors before and after bariatric surgery. The findings revealed that, despite reductions in inflammation markers in blood plasma and tissue biopsies, the cellular mechanisms regulating inflammation in ADSCs do not fully revert to normal within two to three years post-weight loss. This indicates that even if systemic health improves, the regenerative and anti-inflammatory functions of fat-derived stem cells remain partially compromised.

The study suggests that while individuals experience health benefits after significant weight reduction, the underlying cellular functions of adipose stem cells do not fully restore. This has implications for the use of ADSCs in regenerative medicine, especially since donor health status influences their therapeutic potential. Researchers are now exploring tissue culture models derived from adipose tissue to better understand these differences, aiming to improve personalized treatment strategies.

Professor Susanna Miettinen's team is planning future experiments involving three-dimensional tissue chips that combine adipose-derived and vascular cells from donors with varying weight statuses. These studies, expected to yield results in 2026, will help decipher the functional disparities and potential for regenerating healthier stem cell populations in individuals with a history of obesity.

Overall, this research emphasizes the importance of considering cellular functionality in post-weight-loss therapies and highlights that obesity's effects on stem cells may persist long after weight is lost. Recovery at the tissue and cellular levels is a gradual process, underscoring the need for ongoing research into optimizing regenerative therapies for obese patients.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

New Insights into Crohn's Disease: Targeting Transcription Factors RUNX2 and BHLHE40

Researchers have identified key transcription factors RUNX2 and BHLHE40 as pivotal in Crohn's disease inflammation. This discovery opens new avenues for targeted therapies to treat and prevent disease relapse.

Advancements in 3D-Printed Human Tissues Enhance Medical Simulation and Training

Innovative 3D printing techniques are now enabling the creation of ultra-realistic human tissue models for enhanced surgical training, offering improved tactile feedback and functionality.

Largest Autism Inpatient Cohort Releases Genetic and Phenotypic Data for Over 1,500 Children

SFARI has released a groundbreaking dataset of genetic and phenotypic data from over 1,500 hospitalized children with autism, focusing on those with profound autism. This resource aims to accelerate research and targeted interventions for individuals with high support needs.

U.S. Health Officials Disinvite Major Medical Organizations from CDC Vaccine Advisory Groups

Major U.S. medical organizations, including the AMA and AAP, have been disinvited from CDC vaccine advisory workgroups, raising concerns about transparency and public trust in vaccine policymaking.